Boulder Hill Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Boulder Hill Capital Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,200	Closed	-$318K	–	190
2023 Q1	$318K	Buy	+13,200	New	+$166K	0.26%	82

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Boulder Hill Capital Management's PRVB Position: Q2 2023 in Review

Boulder Hill Capital Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 13,200 shares — an estimated $318K sold.

Boulder Hill Capital Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $318K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Boulder Hill Capital Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Boulder Hill Capital Management sold 13,200 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $318K.
Boulder Hill Capital Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Boulder Hill Capital Management's Provention Bio, Inc. Common Stock position peaked at $318K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Boulder Hill Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.